FREDERICK F. LANG, M.D.
Radiology at Holcombe Blvd, Houston, TX

License number

Texas K0888

Personal information

See more information about FREDERICK F. LANG at radaris.com

Name

Address

Phone

Frederick Lang, age 48

7726 N Perry St APT 3, Baytown, TX 77521

(281) 253-8412

Frederick Lang, age 85

15816 Waters Edge Way, Tyler, TX 75703

Frederick Lang

2932 Carnegie St, Houston, TX 77005

(713) 248-4857

Frederick Lang

2428 Hillary Trl, Mansfield, TX 76063

Frederick Lang

202 N Louise St, Atlanta, TX 75551

(903) 895-4661

Professional information

See more information about FREDERICK F. LANG at trustoria.com

Dr. Frederick F Lang, Houston TX - MD (Doctor of Medicine)

Specialties:

Neurosurgery

Address:

MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
(713) 792-6600 (Phone)

Certifications:

Neurosurgery, 2000

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030

Education:

Medical School
Yale University School Of Medicine
Graduated: 1988
New York University Med Center
Graduated: 1989
Graduated: 1995
MD Anderson Canc Center
Graduated: 1996
Yale College, Yale University
Graduated: 1984

Frederick F Lang, Houston TX

Specialties:

Neurosurgeon

Address:

1515 Holcombe Blvd, Houston, TX 77030

Education:

Yale University, School of Medicine - Doctor of Medicine

Board certifications:

American Board of Neurological Surgery Certification in Neurological Surgery

Frederick F Lang, Houston TX

Specialties:

Neurological Surgery, Medical Genetics, Surgical Oncology

Work:

MD Anderson Cancer Ctr
1515 Holcombe Blvd, Houston, TX 77030

Education:

Yale University (1988)

Conditionally Replicative Adenovirus To Target The Rb And Rb-Related Pathways

US Patent:

2003013, Jul 24, 2003

Filed:

Apr 17, 2002

Appl. No.:

10/124608

Inventors:

Juan Fueyo - Houston TX, US
Athanassios Kyritsis - Stavraki, GR
Polly Lee - Houston TX, US
Victor Levin - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houston TX, US

International Classification:

A61K048/00, C12N007/00, C12N015/861

US Classification:

424/093200, 435/235100, 435/456000

Abstract:

The present invention involves a method of treating cancer using a mutant adenovirus that is targeted to cells with a mutant retinoblastoma pathway. The mutant adenovirus is able to kill the tumor cells without harming the cells with a wild type retinoblastoma pathway.

Oncolytic Adenovirus Armed With Therapeutic Genes

US Patent:

2006014, Jul 6, 2006

Filed:

Mar 10, 2005

Appl. No.:

11/077513

Inventors:

Juan Fueyo - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houston TX, US

International Classification:

A61K 48/00

US Classification:

424093200

Abstract:

The present invention involves compositions and methods for treating cancer using a mutant adenovirus comprising a polynucleotide encoding a therapeutic polypeptide that is targeted to cells with a mutant retinoblastoma pathway. The mutant adenovirus is able to kill the tumor cells without harming cells with a wild type retinoblastoma pathway.

Combination Therapy With Oncolytic Adenovirus

US Patent:

2007029, Dec 20, 2007

Filed:

Mar 2, 2007

Appl. No.:

11/681592

Inventors:

Juan Fueyo - Houston TX, US
Charles Conrad - Spring TX, US
Frederick Lang - Houston TX, US

International Classification:

A01N 63/00, A61K 38/00, A61P 43/00

US Classification:

424093600, 514002000

Abstract:

The present invention involves compositions and methods for treating cancer using a combination of cell cycle modulating agent(s) and anticancer agents or therapies, particularly S-phase specific therapies.